Trial NCT02138812

View at ClinicalTrials.gov 
Org. Study IDs: 16804

Last trial update was posted on 2018-10-12

MeSH Interventions

Paclitaxel

MeSH Conditions

Neoplasms

Other Conditions

Medical Oncology

Stopping Reasons

As another Mps1 inhibitor was being developed in parallel, the strategic decision was to move forward with the development of the follow up compound only.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID